Clinical Trial Update: Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial of radiotherapy and temozolomide with dichloroacetate for newly diagnosed glioblastoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Dichloroacetate (dichloroacetate)
• Temodar (Temozolomide)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Glioblastoma | Phase 1 | Status: WITHDRAWN